Filing Details
- Accession Number:
- 0001179110-16-027623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-13 13:15:16
- Reporting Period:
- 2016-07-11
- Filing Date:
- 2016-07-13
- Accepted Time:
- 2016-07-13 13:15:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566865 | Marie Jeanine Jiganti | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-11 | 938 | $48.68 | 5,716 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-11 | 585 | $78.07 | 5,131 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-07-11 | 353 | $78.51 | 4,478 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-07-11 | 938 | $78.51 | 3,840 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2016-07-11 | 938 | $0.00 | 938 | $48.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-07-09 | 2017-07-09 | No | 4 | M | Direct |
Footnotes
- The exercise and sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.
- Represents the weighted average sale price of $78.5118. The range of prices for the sale of these shares was $78.49 - $78.53, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of $78.5131. The range of prices for the sale of these shares was $78.49 - $78.52, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The Stock Appreciation Rights were granted on 7/9/2012. 25% vested on 7/9/2013, then 6.25% vested every three months thereafter.
Billionaire Hedge Funds
